SCHEMBL6207367

SCHEMBL6207367

COc1ccc(N(CC(C)Cc2cnc(Cl)nc2Cl)C(=O)Nc2ccccc2)cc1

nearest known ligand 0.47

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.47
POLB P06746 2/20 0.42
SMN1; SMN2 Q16637 6/20 0.41
CNR1 P21554 1/20 0.40
TP53 P04637 4/20 0.40
KMT2A Q03164 3/20 0.39
MEN1 O00255 2/20 0.39
NPY5R Q15761 1/20 0.39
GAA P10253 1/20 0.38
HTT P42858 1/20 0.38
KLK7 P49862 1/20 0.38
MAPT P10636 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4687567 0.88 LMNA (0.56) LMNAPOLBSMN1; SMN2CNR1TP53
SCHEMBL6202984 0.74 MAPT (0.42) SMN1; SMN2KMT2AMEN1GAAHTT
SCHEMBL4689918 0.73 PTGIR (0.45) LMNASMN1; SMN2TP53KMT2AMEN1
SCHEMBL6205797 0.72 GAA (0.45) SMN1; SMN2TP53KMT2AMEN1GAA
SCHEMBL5795287 0.72 SMN1; SMN2 (0.38) LMNAPOLBSMN1; SMN2TP53KMT2A
SCHEMBL6205153 0.71 SMN1; SMN2 (0.35) LMNASMN1; SMN2TP53KMT2AGAA
SCHEMBL4764854 0.70 CCKAR (0.45) POLB
SCHEMBL5831973 0.70 SMN1; SMN2 (0.39) LMNAPOLBSMN1; SMN2TP53KMT2A
SCHEMBL5831974 0.70 SMN1; SMN2 (0.39) LMNAPOLBSMN1; SMN2TP53KMT2A
SCHEMBL4764898 0.69 ESR1 (0.42) SMN1; SMN2KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1560832-A1 PYRIMIDO 4,5-D PYRIMIDINE DERIVATIVES WITH ANTICANCER ACTIVITY F. HOFFMANN-LA ROCHE AG (CH) 2005-08-10 EP disclosed
WO-2004041822-A1 PYRIMIDO[4,5-D]PYRIMIDINE DERIVATIVES WITH ANTICANCER ACTIVITY F. HOFFMANN-LA ROCHE AG (CH) 2004-05-21 WO disclosed